Abstract
The typical behavioral characteristics of the night eating syndrome have been described as morning anorexia, evening hyperphagia and insomnia. The neuroendocrine characteristics have been described as changes in the circadian rhythm by an attenuation in the nocturnal rise of the plasma concentrations of melatonin and leptin and an increased circadian secretion of cortisol. The night eaters also have an overexpressed hypothalamic-pituitary-adrenal axis with an attenuated response to stress. The night eating syndrome appears to represent a new eating disorder, different from the established disorders of anorexia nervosa, bulimia nervosa, and binge eating disorders. It differs in the frequency and size of ingestions at night, and the elevated plasma levels of cortisol reflect increased activity of CRH, as expressed by an attenuated ACTH and cortisol response. In conclusion the mechanisms behind the increased CRH stimulation may involve alterations in the neurotransmitter systems, causing increased nocturnal appetite and disruption in the sleep pattern. This may, to some extent, explain the disturbances in the circadian secretions of melatonin and leptin and the behavioral characteristics of the night eating syndrome.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Stunkard AJ, Grace WJ, Wolff HG. The night-eating syndrome. A pattern of food intake among certain obese patients. Am J Med 1955; 19:78–86.
Rand CSW, Macgregor MD, Stunkard A. The night eating syndrome in the general population and among post-operative obesity surgery patients. Intl J Eat Disord 1997; 22:65–69.
Stunkard AJ. Eating patterns and obesity. Psychiatry Quarterly 1959; 33:284–294.
Rand CS, Kuldau JM. Morbid obesity: A comparison between a general population and obeseity surgery patients. Int J Obes Relat Metab Disord 1993; 17:657–661.
Adami GF, Meneghelli A, Scopinaro N. Night eating and binge eating disorder in obese patients. Intl J Eat Disord 1999; 25:335–338.
Gluck ME, Geliebter A, Satov T. Night eating syndrome is associated with depression, low self-esteem, reduced daytime hunger, and less weight loss in obese outpatients. Obes Res 2001; 9(4):264–7.
Birketvedt G, Florholmen J, Sundsfjord J et al. Behavioral and neuroendocrine characteristics of the night-eating syndrome. JAMA 1999; 282:657–663.
Berry EM, Growdon JH, Wurtman JJ et al. A balanced carbohydrate: Protein diet in the management of Parkinson’s disease. Neurology 1991; 41:1295–1297.
Yokogoshi H, Wurtman RJ. Meal composition and plasma amino acid ratios: Effects of various proteins or carbohydrates, and of various protein concentrations. Metabolism 1986; 35:637–642.
Birketvedt GS, Sundsfjord J, Florholmen JR. Hypothalamic-pituitary-adrenal axis in the night eating syndrome. Am J Physiol Endocrinol Metab 2002; 282(2):E366–9.
Grilo CM, Shiffman S. Longitudinal investigation of the abstinence violation effect in binge eaters. J Consult Clin Psychol 1994; 62:611–619.
Kennedy SH, Garfinkel PE, Parienti V et al. Changes in melatonin levels but not cortisol levels are associated with depression in patients with depression and eating disorders. Arch Gen Psychiatry 1989; 46:73–78.
Schenk CH, Mahowald MW. Review of nocturnal sleep-related eating disorders. Intl J Eat Disord 1994; 16:343–356.
Manni R, Ratti MT, Tartara A. Nocturnal eating: Prevalence and features in 120 insomniac referrals. Sleep 1997; 20:734–8.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2006 Landes Bioscience/Eurekah.com and Springer Science+Business Media
About this chapter
Cite this chapter
Birketvedt, G.S., Florholmen, J.R. (2006). The Night Eating Syndrome. In: Sleep and Sleep Disorders. Springer, Boston, MA. https://doi.org/10.1007/0-387-27682-3_28
Download citation
DOI: https://doi.org/10.1007/0-387-27682-3_28
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-27681-6
Online ISBN: 978-0-387-27682-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)